Esmolol and Labetalol in ECT

Phase 3

• Conditions: Condition 1: Blood Pressure. Condition 2: Heart Rate.; Elevated blood-pressure reading, without diagnosis of hypertension; Tachycardia, unspecified; R03.0; R00.0

• Registration Number: IRCT20160307026950N19
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Candidate for electroshock therapy
Range of 13 to 19 years
ASA class I and II
The patient's consent to participate in the study

Exclusion Criteria

Contraindications to the use of Esmolol and Labetalol
Previous consumption of beta-blockers
Sensitivity to Esmolal and labetalol
Asthma and drug allergies
History of severe cardiovascular disease, chronic respiratory disease, kidney disease, and liver disease

Study & Design

• Study Type: interventional
• Study Design: Not specified